203 results

Research & Innovation

Posted on 01.07.2022

Putting medical technologies at the heart of health innovation in Europe

From robotic surgery and wearables to connected devices and AI-powered diagnostics, medical technologies are reinventing healthcare. Europe’s medtech sector is making unprecedented investments in research & innovation – and joining the Innovative Healthcare Initiative for the first time. I sense that something big is happening in healthcare research. A tectonic shift in Europe’s health innovation […]

By Patrick Boisseau Director Research and Innovation, MedTech Europe

Access

Posted on 07.06.2022

Bringing down the barriers to healthcare access

COVID-19 has changed healthcare industry forever. The unparalleled demands placed on healthcare systems have disrupted old ways and exposed cracks but also opened our eyes to new possibilities. I was so inspired to see people pulling together, refusing to give up, and our industry showing a resilience to bring innovations to the market that positively […]

By Claire Wallace President, Microbiology Specialty Diagnostic Group Thermo Fisher Scientific

shutterstock_1569192532
Digital

Posted on 07.12.2021

What’s Next for Digital Health After COVID-19?

Microsoft CEO Satya Nadella remarked earlier this year that the first months of the COVID-19 pandemic saw ’two years of digital transformation in two months‘. As the world moved to working, shopping, and socialising online, necessity drove many aspects of healthcare to being delivered remotely too. With vaccines being rolled out around the world and […]

By Naveed Khan Director of Commercial and Business Development – Digital Health at BIOTRONIK

shutterstock_1773473690
COVID-19

Posted on 25.11.2021

Testing Times: we have the tools to meet next healthcare challenges

As Europe enters the fourth wave of COVID-19 and countries start to impose lockdown restrictions, we must not forget that we have the tools to tackle this. European society has undergone a profound transformation since the start of the COVID-19 pandemic. Testing has been placed at the heart of our health systems as one of the […]

By Martyna Giedrojc Director International Public Affairs and Professionals Relations Europe at Cepheid

shutterstock_1126283543
Global

Posted on 22.11.2021

AMR action plans – what are we missing?

The recent pandemic has bluntly exposed some of the gaps in our healthcare systems across Europe and one thing stuck with me the most: we were not prepared. In many ways, we can think of this as a test run of how the world responds to large-scale healthcare crises. There are more complex threats ahead, […]

By Johanna Engelage Team Leader of Marketing Urinalysis at Sysmex Europe GmbH

shutterstock_322448540
Regulation

Posted on 19.11.2021

EU move on mergers threatens innovation

At first sight, EU policy on mergers and acquisitions might not need to concern patients and frontline healthcare workers too much. However, a subtle shift in the rules on whether two companies can agree to become one could have a profound impact on access to medical innovation. To understand why this might be, it’s important […]

By Aline Lautenberg General Counsel and Director General Legal & Compliance, MedTech Europe

shutterstock_1246645873
Value

Posted on 17.03.2021

MedTech Slovenia: building the future together

  The next chapter in the story of Slovenia’s medical technology industry has begun – and it is being co-written by leaders from the in-vitro diagnostics and medical devices sectors. SIEDMA and SLO-MED have formally merged to become MedTech Slovenia. Together, we are combining our expertise to speak for our diverse industry with one voice. […]

By Peter Bratusek President, MedTech Slovenija

shutterstock_430010287
Value

Posted on 02.02.2021

Biobanks and medtech: an underdeveloped partnership

Unlocking academia-industry collaboration on sample collection, storage and sharing  COVID-19 has demonstrated that access to quality samples and clinical data is key to facing any healthcare challenge. Millions of people have been tested around the world, generating an enormous number of samples and patients’ data.  Of course, swabs can have a life after the results […]

By Francesco Florindi Strategy & Partnership Manager, BBMRI-ERIC

shutterstock_1198926103
COVID-19

Posted on 26.11.2020

In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations

In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic. The remaining IVDR transition time is not sustainable and requires attention […]

By Natale Bova Chair of the Regulatory IVD Forum of Confindustria Dispositivi Medici